Keith T. Flaherty
Director, and Chair of the SAB
Clinical Research
LOXO GMBH
United States of America
Biography
Dr. Keith T. Flaherty has served as SAB Chair since company inception, and sits on the board of directors. Dr. Flaherty is currently Director of Clinical Research and the Henri and Belinda Termeer Center for Targeted Therapy, Massachusetts General Hospital Cancer Center, and is a Professor of Medicine at Harvard Medical School. Dr. Flaherty trained in internal medicine at Brigham and Women’s Hospital, and in medical oncology at the University of Pennsylvania, earning board certification in these specialties. He received his M.D. from The Johns Hopkins School of Medicine and his B.S. degree from Yale University.
Research Interest
medical oncology
